Cargando…
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results
Background: BNT162b2 and mRNA-1273 are the two recently approved mRNA-based vaccines against COVID-19 which has shown excellent safety and efficacy. Preliminary data about specific and neutralizing antibodies is available covering the first 100 days after vaccination. Methods: We reviewed all the pu...
Autores principales: | Lombardi, Andrea, Bozzi, Giorgio, Ungaro, Riccardo, Villa, Simone, Castelli, Valeria, Mangioni, Davide, Muscatello, Antonio, Gori, Andrea, Bandera, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994748/ https://www.ncbi.nlm.nih.gov/pubmed/33777055 http://dx.doi.org/10.3389/fimmu.2021.657711 |
Ejemplares similares
-
Immune Checkpoint Inhibitors in People Living with HIV/AIDS: Facts and Controversies
por: Castelli, Valeria, et al.
Publicado: (2021) -
Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation
por: Alagna, Laura, et al.
Publicado: (2020) -
Transient increase in plasma HIV RNA after COVID-19 vaccination with mRNA-1272
por: Bozzi, Giorgio, et al.
Publicado: (2021) -
Nocardia Infections in the Immunocompromised Host: A Case Series and Literature Review
por: Palomba, Emanuele, et al.
Publicado: (2022) -
T-Cell Exhaustion in Mycobacterium tuberculosis and Nontuberculous Mycobacteria Infection: Pathophysiology and Therapeutic Perspectives
por: Lombardi, Andrea, et al.
Publicado: (2021)